Jump Search | Advanced Search
HOME PAGE FOR THE WORLD'S BUSINESS LEADERS
 
Home > Business
 
   News Scan
News Scan P.M.: July 19, 2025

NEW YORK - Business, technology and wealth news:

ConAgra Recalls Huge Amount Of Beef, 16 Sick
ConAgra Foods launched the nation's second-largest recall of ground beef after the U.S. Agriculture Department said the meat may be contaminated with a deadly bacteria that sickened at least 16 people.

U.S. Officials Subpoena Mercedes On Price Fixing
Federal officials have launched a criminal investigation into allegations that Mercedes colluded with dealers to fix prices on cars sold in the New York area, DaimlerChrysler AG said.

HPL Launches Accounting Probe, Ousts CEO
Software maker HPL Technologies said it was investigating suspected accounting irregularities and had ousted its chairman and chief executive.

United Caps Record Second-Quarter Air Industry Loss
Major U.S. air carriers lost $1.4 billion in the second quarter, the most ever for that reporting period, as Friday's steep losses and gloomy outlook from United Airlines capped a week of airline earnings reports stained with red ink.

Tougher U.S. Business Reform Bill Is Basis For Talks
Under growing political pressure to move against business scandals, U.S. lawmakers took the tougher of competing reform bills as the basis for negotiations on a final measure that could be drafted within days.

SEC's Pitt Downplays Fears Of Restatements Wave
SEC Chairman Harvey Pitt, battling a crisis in market confidence, said he expected most companies would meet an SEC deadline next month to certify their most recent financial results.

Nicor Plunges To 10-Year Low On Accounting Woes
With its shares plunging about 50% to a 10-year low, Nicor is the latest company to suffer from accounting woes, in this case coming from a joint venture with Dynegy.

Merck Posts Roughly Flat Profit Vs. Year Ago
Merck & Co. said its quarterly profit was little changed from a year earlier, as strong sales of its high-cholesterol and osteoporosis medicines were offset by falling sales of drugs facing generic competition.

J&J Confirms FDA Probe, Believed Related To Eprex
Shares of Johnson & Johnson tumbled to a 16-month low after federal regulators began probing allegations of fraudulent record-keeping at a plant that makes one of the health care giant's best-selling medicines.

U.S. Trade Gap A Record As Consumers Snap Up Imports
The U.S. trade deficit swelled to a record in May on strong consumer demand, while tame inflation data solidified expectations the Federal Reserve will keep interest rates low.

Earlier headlines

Ford's Lincoln Mercury Chief Steps Down

UAL Posts $341M Loss As Revival 'Stalled'

R.J. Reynolds Q2 Profit Up

J&J: No link Between Allegations, Disorder

Microsoft Extends Decline On Cautious Outlook

Avon Q2 Profit Prettier

Sun Shares Plunge 21%

AOL Time Warner Named In Shareholder Suit

Vivendi To Postpone H1 Results

Samsung Q2 Net More Than Doubles



News items can be submitted to Gregory Levine at glevine@forbes.net or by calling him at (212) 366-8851.





1 of 1

E-mail story
Send comments
Print story
Request a reprint


Save $64
on your Forbes Subscription!
17 issues for only $19.99
Risk-Free Money-Back Guarantee
Tell us where to send your copies of Forbes:  
Name:

Address:

State:          Zip:
   
  Email:

City:


 
Click 'Continue' to view offer terms  
 

  
E-Mail Alerts

Companies
  RJR
  MRK
  MER
  AVP
Topics
  Tyco
  Avon
  UAL
  Merck
Enter E-Mail Address:

FAQ
Privacy Policy
Related stories

Faces Of The Week: Aug. 12 - 16, 2002
Top Pickers Buying Drugs And Fresh Fruit
Faces In The News: Aug. 15, 2002

Related quotes

14.05 + 0.69
48.16 + 0.00
25.73 - 0.07
46.00 + 0.45
16.76 + 0.31
36.86 - 0.57
51.81 + 1.17
58.15 - 0.87
45.20 + 1.20
4.09 + 0.05
16.18 + 0.83
3.20 - 0.02
8/21/02 12:29:00 PM ET

Expert Advice to Help Put Your Portfolio in the Best Shape

Forbes.com offers you access to some of the world's best investment advisors and commentators. Combine our helpful analysis with our useful investing tools to make the most of your investments.

Analysis:

Commentary:

  • Portfolio Strategy

Tools:

  • Fund Screener
  • Corporate Events Calendar

  

  

 
 
Reprints / Permissions       Subscriber Services       Ad Information       Privacy Statement
© 2002 Forbes.com™      All Rights Reserved       Terms, Conditions and Notices
 

 

  
Market data provided by Reuters. Disclaimer
Stock quotes are delayed at least 15 minutes for Nasdaq, at least 20 minutes for NYSE/AMEX.
U.S. indexes are delayed at least 15 minutes with the exception of S&P; 500 which is real-time.
Forbes 40 Index powered by Telemet.
News may include latest headlines from Reuters.